Moreover, recent research indicates that MMP-9 is an effective target for treating cerebral infarction, and the drugs that inhibit MMP-9 expression could maintain the integrity of the BBB and reduce cerebral edema [19]. This evidence concerns the gene MMP9 and cerebral infarction.